Location: Home
  • search
  • go
  • Relate News
  • 5/14/2019Big Pharma Companies Deliver Stunning Chinese Growth in Q1/2019 and 20...
  • 5/14/2019Onconova and HanX Biopharma Enter License Agreements for Anticancer Ri...
  • 5/14/2019New Report: As Star mAb Drug Patents Expire, Generic Drugs will Shock ...
  • 5/14/2019Peritech Pharma Granted Drug Delivery Patents for China and Russia
  • 5/13/2019China to Raise Reimbursement Ratio of Critical Illness Program to 60% ...
  • 5/13/2019NMPA Deepens Regulatory Harmonization with Hong Kong and Macau
  • 5/10/2019Recent Executive Moves
  • 5/10/2019PhRMA Calls for Trade Deals That Force Countries to Pay More for Drugs
  • 5/10/2019China Issues Draft Positive List of Antibacterial Active Ingredients
  • 5/10/2019Latest Draft of Drug Administration Law Proposes to Ban Platform-based...
  • 5/9/2019NMPA Issues 2018 Food and Drug Regulatory Statistics Annual Report
  • 5/9/2019NHC Minister Outlines Future Healthcare Reform Direction
  • 5/9/2019China Investigates Several Senior Local Drug Regulators for Corruption
  • 5/9/2019China Built 158 Internet Hospitals and Telemedicine Platforms in 19 Pr...
  • 5/9/2019Chinese Health Expenditure Projected to Reach 9.1% of GDP by 2035
  • 5/9/2019China Cashes In on the Cannabis Boom
  • 5/9/2019Chinese Bioethicists Call for 'Reboot' of Biomedical Regulation after ...
  • 5/9/2019Allergan Launches $14.7M Innovation Center with China Optimism
  • 5/9/2019Alipay's Mutual Aid Platform Xiang Hu Bao Now Covers Chinese Senior Ci...
  • 5/9/2019Innovent-Lilly Partnership Announces Positive Clinical Results of Ritu...
  • 5/9/2019Helsinn and Mundipharma Launch Cancer Care Drug ALOXI IV in China
  • 5/9/2019InnoCare PharmaTech Plans to $250M IPO in Hong Kong
  • 5/9/2019Recent Chinese Study links Diabetes and Numerous Cancers
  • 5/9/2019Amerigen Announces USFDA Approval for Generic Penicillamine
  • 5/9/2019Progressive Reforms Shifting the Cancer Medicine Landscape in China
  • 5/9/2019Alembic Pharma Forms Chinese Joint Venture
  • 5/8/2019Chinese Pharma Billionaire Paid $6.5M to Get Daughter into Stanford
  • 5/8/2019Research Point Global and WuXi CDS to Rebrand as WuXi Clinical
  • 5/8/2019Merck's Successful First Quarter Largely Driven by China Growth
  • 5/8/2019CDE Publicizes Four More Drug Applications To Be Granted Priority Revi...
  • Page:283/775 Total number of articles:23235: [First][<<] [281] [282] [283] [284] [285] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group